Epinephrine and anaphylaxis outcomes
- 1 November 2024
- journal article
- editorial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 133 (5) , 501-502
Abstract
No abstract availableFunding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases Division of Intramural Research (K23AI175525)
This publication has 8 references indexed in Scilit:
- Outcomes associated with prehospital epinephrine in adult and pediatric patients with anaphylaxisAnnals of Allergy, Asthma & Immunology, 2024
- Anaphylaxis: A 2023 practice parameter updateAnnals of Allergy, Asthma & Immunology, 2023
- Anaphylaxis knowledge gaps and future research priorities: A consensus reportJournal of Allergy and Clinical Immunology, 2022
- Severity grading system for acute allergic reactions: A multidisciplinary Delphi studyJournal of Allergy and Clinical Immunology, 2021
- Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi studyJournal of Allergy and Clinical Immunology, 2020
- Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysisJournal of Allergy and Clinical Immunology, 2020
- Further Evaluation of Factors That May Predict Biphasic Reactions in Emergency Department Anaphylaxis PatientsThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency departmentAnnals of Allergy, Asthma & Immunology, 2017